Epigenetic Targets and Pathways Linked to SARS-CoV-2 Infection and Pathology.
Ali A RabaanMohammed Mubarak AljeldahBasim R Al ShammariRoua A AlsubkiJawaher M Al-OtaibiYousef N AlhashemNeda A AlaliTarek SulaimanZainab AlsalemHuda A BajunaidMohammed GaroutHeba A AlsaffarSouad A AlmuthreeDoha HudhaiahAzhar M AlzaherFatimah A AlshaikhAmer Mohammad AlshengetiMustafa A NajimRamadan Abdelmoez FarahatRanjan K MohapatraPublished in: Microorganisms (2023)
The scale at which the SARS-CoV-2/COVID-19 pandemic has spread remains enormous. Provided the genetic makeup of the virus and humans is readily available, the quest for knowing the mechanism and epidemiology continues to prevail across the entire scientific community. Several aspects, including immunology, molecular biology, and host-pathogen interaction, are continuously being dug into for preparing the human race for future pandemics. The exact reasons for vast differences in symptoms, pathophysiological implications of COVID-infections, and mortality differences remain elusive. Hence, researchers are also looking beyond traditional genomics, proteomics, and transcriptomics approach, especially entrusting the environmental regulation of the genetic landscape of COVID-human interactions. In line with these questions lies a critical process called epigenetics. The epigenetic perturbations in both host and parasites are a matter of great interest to unravel the disparities in COVID-19 mortalities and pathology. This review provides a deeper insight into current research on the epigenetic landscape of SARS-CoV-2 infection in humans and potential targets for augmenting the ongoing investigation. It also explores the potential targets, pathways, and networks associated with the epigenetic regulation of processes involved in SARS-CoV-2 pathology.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- coronavirus disease
- single cell
- dna methylation
- endothelial cells
- gene expression
- genome wide
- human health
- induced pluripotent stem cells
- healthcare
- risk factors
- pluripotent stem cells
- mass spectrometry
- copy number
- mental health
- type diabetes
- risk assessment
- cardiovascular disease
- climate change
- candida albicans
- current status